Serum SRH antibody level as a measure of the immunity against natural and artificial A/Victoria/3/75 infections
- PMID: 342314
Serum SRH antibody level as a measure of the immunity against natural and artificial A/Victoria/3/75 infections
Abstract
A natural influenza A/Victoria/3/75 outbreak occurred in two communities where part of the residents had been vaccinated with a live recombinant vaccine strain, the RIT 4025 strain (A/Scotland/840/74 serotype). Using the single radial hemolysis technique to measure the antibody level, a relationship was established between the rate of infection and the pre-epidemic serum antibody titer. The higher the pre-epidemic antibody titer, the lower the rate of infection and illness. The protective titer 50% (PT 50) against infection was equal to 26.7 mm2. The same calculation was applied to a population of placebo recipients and RIT 4025 vaccinees challenged with a virulent A/Victoria/3/75 strain. Although the number of volunteers was much smaller, the same correlation was found for the infection detected by a significant antibody rise and for confirmed illness.
Similar articles
-
Correlation between rate of infection and preexisting titer of serum antibody as determined by single radial hemolysis during and epidemic of influenza A/Victoria/3/75.J Infect Dis. 1978 Feb;137(2):194-6. doi: 10.1093/infdis/137.2.194. J Infect Dis. 1978. PMID: 342641
-
[Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine].Boll Ist Sieroter Milan. 1976 Mar;55(71):1-12. Boll Ist Sieroter Milan. 1976. PMID: 1021151 Italian.
-
Live attenuated influenza virus vaccine trial in children.Pediatrics. 1975 Dec;56(6):991-8. Pediatrics. 1975. PMID: 1196767
-
Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community.Dev Biol Stand. 1976;33:197-201. Dev Biol Stand. 1976. PMID: 782969 Clinical Trial.
-
Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity.N Engl J Med. 1977 Apr 14;296(15):829-34. doi: 10.1056/NEJM197704142961501. N Engl J Med. 1977. PMID: 846492
Cited by
-
Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine.Influenza Other Respir Viruses. 2008 May;2(3):93-8. doi: 10.1111/j.1750-2659.2008.00039.x. Influenza Other Respir Viruses. 2008. PMID: 19453468 Free PMC article. Clinical Trial.
-
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses.Influenza Other Respir Viruses. 2018 Nov;12(6):675-686. doi: 10.1111/irv.12591. Epub 2018 Aug 11. Influenza Other Respir Viruses. 2018. PMID: 30019448 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical